Fibromuscular dysplasia in argentina. a registry from the secondary hypertension working group of the argentine society of hypertension (sahara-df). project protocol and preliminary results
Article Sidebar
Main Article Content
Abstract
In Argentina there are no epidemiological data regarding fibromuscular dysplasia. Building a National Registry may provide information leading to updated consensus and recommendations for a correct diagnosis, assessment and treatment. Data gathering for the Argentine Registry of Fibromuscular Dysplasia (SAHARA-DF) was initiated in October 2015. By 2019, 49 patients were confirmed (44 women, 38 hypertensives, age 45.3 ± 17.2 years, 12 with a neurological presentation). Twenty-two patients had multi-site vascular lesions, in spite of a diagnosis bias due to lack of supporting studies in almost half of the cases. The renovascular site was the most affected, followed by the carotid and iliac sites, and multifocal lesions were more frequent than unifocal (35 versus 14, respectively). Associated aneurysms were found in 13 cases, and arterial dissection in 4. Twenty-two renal angioplasties were performed, 14 with stent placement. In this preliminary study of an Argentinian population, the systemic nature of the disease is evidenced, and a call for action arises regarding the need for discussing the diagnostic algorithm and treatment method.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Persu A, Giavarini A, Touzé E, et al., ESH Working Group Hyper-tension and the Kidney. European consensus on the diagnosis and ma-nagement of fibromuscular dyspla-sia. J Hypertens. 2014; 32:1367-78. DOI: https://doi.org/10.1097/HJH.0000000000000213
Kim ESH, Olin JW, Froehlich JB, et al. Clinical manifestations of fibromuscular dysplasia vary by pa-tient sex:a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol. 2013; 62:2026-8. DOI: https://doi.org/10.1016/j.jacc.2013.07.038
Plouin P-F, Baguet J-P, Thony F, et al., ARCADIA Investigators. High Prevalence of Multiple Arterial Bed Lesions in Patients with Fibro-muscular Dysplasia:The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hyper-tension. 2017; 70:652-8. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.117.09539
Dyke CK, Calif RM. National and regional registries:what good are they? Eur Heart J. 2000; 21:1401-3. DOI: https://doi.org/10.1053/euhj.2000.2304
Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019; 24(2):164-89. DOI: https://doi.org/10.1177/1358863X18821816
Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia:results in the first 447 patients. Circulation. 2012; 125:3182-90. DOI: https://doi.org/10.1161/CIRCULATIONAHA.112.091223
Wang LC, Scott DJ, Clemens MS, et al. Mechanism of Stent Failure in a Patient with Fibromuscular Dyspla-sia following Renal Artery Stenting. Annals of Vascular Surgery. 2015; 29:123.e19-123.e21. DOI: https://doi.org/10.1016/j.avsg.2014.08.002
Raju MG, Bajzer CT, Clair DG, et al. Renal artery stent fracture in pa-tients with fibromuscular dysplasia:a cautionary tale. Circ Cardiovasc Interv. 2013; 6:e30-1. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.000193
Joux J, Chausson N, Jeannin S, et al. Carotid-bulb atypical fibromus-cular dysplasia in young Afro-Ca-ribbean patients with stroke. Stroke. 2014; 45:3711-3. DOI: https://doi.org/10.1161/STROKEAHA.114.007313
Maas AHEM, Bouatia-Naji N, Persu A, et al. Spontaneous coronary artery dissections and fibromuscular dysplasia:Current insights on patho-physiology, sex and gender. Int J Cardiol.2019; 286:220-5. DOI: https://doi.org/10.1016/j.ijcard.2018.11.023
Talarowska P, Dobrowolski P, Klisiewicz A, et al. High inciden-ce and clinical characteristics of fibromuscular dysplasia in patients with spontaneous cervical artery dissection:The ARCADIA-POL study. Vasc Med. 2019; 24(2):112-9. DOI: https://doi.org/10.1177/1358863X18811596
Henrard C, Belge H, Fas-tré S, et al. Cervical artery dissection:fibromuscular dysplasia versus vascular Ehlers-Danlos syn-drome. Blood Press. 2019; 28:139-43. DOI: https://doi.org/10.1080/08037051.2018.1557507
O’Connor S, Kim ES, Brinza E, et al. Systemic connective tissue features in women with fibromus-cular dysplasia. Vasc Med. 2015; 20:454-62. DOI: https://doi.org/10.1177/1358863X15592192
Farkašová Iannaccone S, Vasovčák P, Sopková D, et al. Arr-hythmogenic Ventricular Cardiom-yopathy Associated With Fibromus-cular Dysplasia of Ostial Right Main Coronary Artery. Am J Forensic Med Pathol. 2019. doi:10.1097/PAF.0000000000000469. DOI: https://doi.org/10.1097/PAF.0000000000000469
Krittanawong C, Kumar A, Johnson KW, et al. Prevalence, Presentation, and Associated Con-ditions of Patients With Fibromus-cular Dysplasia. Am J Cardiol. 2019; 123:1169-72. DOI: https://doi.org/10.1016/j.amjcard.2018.12.045
Shoja T, Basman C, Jain S, et al. Postpartum Sudden Cardiac Death After Spontaneous Coronary Artery Dissection in a Patient With Fibro-muscular Dysplasia. Cardiol Res. 2017; 8:327-30. DOI: https://doi.org/10.14740/cr587w
Vance CJ, Taylor RN, Craven TE, et al. Increased prevalence of pree-clampsia among women undergoing procedural intervention for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2015; 29:1105-10. DOI: https://doi.org/10.1016/j.avsg.2015.03.037
Cunningham TK, Draper H, Ra-jesh U. Management of a pregnancy with underlying fibromuscular dys-plasia with a history of stroke and carotid artery dissection. J Obstet Gynaecol. 2019; 39(3):417-9. DOI: https://doi.org/10.1080/01443615.2018.1491961
Dobrowolski P, Januszewicz M, Klisiewicz A, et al. Echocardiogra-phic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia:the ARCADIA-POL study. J Hypertens. 2018; 36:1318-25. DOI: https://doi.org/10.1097/HJH.0000000000001706
Ganesh SK, Morissette R, Xu Z, et al. Clinical and biochemical pro-files suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J. 2014; 28:3313-24. DOI: https://doi.org/10.1096/fj.14-251207
Di Monaco S, Georges A, Lenge-lé J-P, et al. Genomics of Fibromus-cular Dysplasia. Int J Mol Sci 2018; 19. doi:10.3390/ijms19051526 DOI: https://doi.org/10.3390/ijms19051526